PANCREATIC CARCINOMA STAGE II

PANCREATIC CARCINOMA STAGE II was reported 640 times

PANCREATIC CARCINOMA STAGE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
1 Provitamin D2 Compound [EPC] 3 0.0001
2 Potassium-sparing Diuretic [EPC] 1 0.0001
3 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
4 Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] 1 0.0001
5 PCSK9 Inhibitor [EPC] 1 0.0000
6 Leukotriene Receptor Antagonist [EPC] 1 0.0000
7 Interleukin-17A Antagonist [EPC] 1 0.0000
8 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
9 Interleukin-23 Antagonist [EPC] 2 0.0000
10 Methylxanthine [EPC] 1 0.0000
11 GLP-1 Receptor Agonist [EPC] 7 0.0000
12 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
13 Microtubule Inhibitor [EPC] 2 0.0000
14 Integrin Receptor Antagonist [EPC] 1 0.0000
15 Central Nervous System Stimulant [EPC] 1 0.0000
16 Prostaglandin Analog [EPC] 1 0.0000
17 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
18 Insulin Analog [EPC] 4 0.0000
19 Sulfonylurea [EPC] 1 0.0000
20 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
21 Fluoroquinolone Antibacterial [EPC] 1 0.0000
22 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
23 Opioid Agonist [EPC] 2 0.0000
24 Factor Xa Inhibitor [EPC] 2 0.0000
25 Leukocyte Growth Factor [EPC] 1 0.0000
26 Proton Pump Inhibitor [EPC] 4 0.0000
27 Aldosterone Antagonist [EPC] 1 0.0000
28 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
29 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
30 Interferon beta [EPC] 1 0.0000
31 Expectorant [EPC] 1 0.0000
32 Loop Diuretic [EPC] 2 0.0000
33 Benzodiazepine [EPC] 3 0.0000
34 Thalidomide Analog [EPC] 2 0.0000
35 Osmotic Laxative [EPC] 1 0.0000
36 Corticosteroid [EPC] 4 0.0000
37 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000